牵手中国医药一哥！中国AI for Science新基建的拼图终于完整了！

TL;DR - AI drug-delivery company METiS Pharmaceuticals will deploy its AiTEM formulation platform locally at Hengrui Pharma to accelerate formulation development. The partnership signals growing adoption of integrated AI and experimental infrastructure within major pharmaceutical R&D workflows.

• AiTEM combines AI models with experimental feedback to screen and optimize formulations, reportedly reducing preclinical optimization from 1–2 years to under three months.
• The broader NanoForge platform integrates formulation, nanoparticle delivery, mRNA sequence, and protein design through shared data, automated experiments, and AI agents.
• METiS says its platform draws on more than 10 million lipid structures and delivery data spanning eight organs or tissue types.
• Local deployment at Hengrui could supply additional real-world experimental data, reinforcing the platform’s model–experiment feedback loop.